MedPath

DOXORUBICIN HCL FOR INJ. U.S.P. 50MG/VIAL

DOXORUBICIN HCL FOR INJ. U.S.P. 50MG/VIAL

Discontinued
DIN Number

02093073

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

david bull laboratories (pty) ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02093073
AIG Number0110825003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01DB01 DOXORUBICIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DOXORUBICIN HYDROCHLORIDEActive
Strength: 50 MG / VIAL
Monograph: DOXORUBICIN HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.